Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 14 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Bikos, Athanasios [Clear All Filters]
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients..
Nephrol Dial Transplant. 34(3), 515-523.
(2019). The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients..
Nephrol Dial Transplant. 35(7), 1277.
(2020). Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients..
J Hypertens. 35(12), 2517-2526.
(2017). A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension..
Am J Nephrol. 48(4), 295-305.
(2018). The Effects of Nebivolol and Irbesartan on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Hemodialysis Patients with Intradialytic Hypertension..
Blood Purif. 1-11.
(2020). The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study..
J Hypertens. 37(2), 432-442.
(2019). Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients..
Am J Nephrol. 40(3), 242-50.
(2014). Heart Failure and Atrial Fibrillation Modify the Associations of Nocturnal Blood Pressure Dipping Pattern With Mortality in Hemodialysis Patients..
Hypertension. 76(4), 1231-1239.
(2020). Lung Ultrasound-Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study..
Am J Kidney Dis. 75(1), 11-20.
(2020). Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension..
Hypertens Res. 42(7), 1001-1010.
(2019). Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA..
Nephrol Dial Transplant. 34(9), 1542-1548.
(2019). Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA..
Nephrol Dial Transplant. 33(10), 1872.
(2018). Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study..
J Hypertens. 38(9), 1849-1856.
(2020). Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes..
J Hypertens. 37(11), 2200-2208.
(2019).